8-K
Selectis Health, Inc. (GBCS)
View as plain text
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 18, 2022
SELECTIS
HEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)
| Utah | 0-15415 | 87-0340206 |
|---|---|---|
| (State or other<br> jurisdiction | Commission | (I.R.S.<br> Employer |
| of incorporation) | File Number | Identification number) |
| 8480 E. Orchard Road, Ste. 4900, Greenwood Village, CO | 80111 | |
| --- | --- | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (720) 680-0808
(Former name or former address, if changed since last report)
| ☐ | Written<br> communications pursuant to Rule 425 under the Securities Act |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act |
| --- | --- |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act |
| --- | --- |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act |
| --- | --- |
Securitiesregistered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM
7.01 REGULATION FD DISCLOSURE
On October 17, 2022, Selectis Health, Inc., a Utah corporation (the “Company”) issued a press release it would present at the 15^th^ annual LD Micro Main Event XV conference on Tuesday, October 25^th^ at 12:30 p.m. Pacific Time.
The information in this Current Report on Form 8-K furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section, and they shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. By filing this Current Report on Form 8-K and furnishing this information pursuant to Item 7.01, The Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including Exhibit 99.1, that is required to be disclosed solely by Regulation FD.
ITEM
9.01: EXHIBITS
| Item | Title |
|---|---|
| 99.1 | Press<br> Release |
| 104 | Cover<br> Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Selectis Health, Inc. | |
|---|---|
| (Registrant) | |
| Dated: October 20, 2022 | /s/ Lance Baller |
| Lance Baller, CEO |
Exhibit99.1
SelectisHealth Appoints Andrew Sink to Board of Directors
-Company Concurrently Announces Resignation of Clifford Neuman as Director and Secretary -
-Sink’s Appointment as Independent Director Fulfills Remaining Corporate Governance Requirements for Major National Exchange Listing-
GreenwoodVillage, CO – October 18, 2022 – Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced that it has appointed Andrew Sink to its board of directors, effective October 17, 2022. Sink’s appointment fills the vacancy resulting from the concurrently announced resignation of Clifford Neuman as a director and secretary for the Company.
With over 30 years of experience in the real estate industry, Sink brings extensive expertise in real estate brokerage and investments. He is the co-founder and manager of Alabama-based commercial real estate investment fund Own Alabama, LLC, as well as the principal and managing director of investment advisory for Colliers International—Alabama. In these roles, he and his team provide investment property advisory, brokerage, investment fund structuring and real estate investment management to high-net-worth families and individuals, as well as advisory services to privately held operating companies seeking to enhance enterprise value through various real estate strategies. Over the course of his career, Sink has been involved in numerous investment transactions and development projects with a combined value of over $700 million, and he has also created and managed six private equity funds and three private family investment funds with a combined value of over $100 million. He earned a Bachelor of Science degree in Commerce and Business Administration with a major in real estate from The University of Alabama.
Sink has previously served on Selectis’s board of directors, and he currently serves as a board of trustees member and secretary of the Eyesight Foundation of Alabama; a board member of Restoration Academy; and a member of the Monday Morning Quarterback Club. Sink is expected to serve on the Company’s standing nominating and governance, audit, and compensation committees.
“With his extensive real estate and investment background, Andy brings a strong perspective to our board as we continue to advance our business transformation,” said Lance Baller, CEO of Selectis. “In addition, his appointment as an independent director enables us to fulfill the remaining corporate governance requirements needed to qualify for a major national exchange listing, which remains one of our top priorities. We would like to thank Cliff Neuman for his years of service and significant contributions to our board and look forward to working alongside Andy to make additional strategic progress.”
AboutSelectis Health
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
For more information, please visit www.selectis.com.
InvestorRelations Contact
Scott Liolios or Jackie Keshner
Gateway Group, Inc.
(949) 574-3860
selectis@gatewayir.com